Atlas Trials

A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI

Clinical trial NCT03236311 · TERMINATED

Trial details

NCT number
NCT03236311
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Microvascular Coronary Artery Disease
Start date
2017-10-12
Primary completion
2018-07-23
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.